In addition, genetically modified mesenchymal stem cells overexpressing G-CSF have also demonstrated immunomodulatory effects by reducing inflammatory mediators, leukocyte infiltration, and myocardial fibrosis (17). This evidence concerns the gene CSF3 and Myocardial fibrosis.